Vir Biotechnology (VIR) Net Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -43.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.32 Mn |
| Dec 31, 2025 | 13,864.00 |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | -895,160.00 |
| Mar 31, 2025 | -403,169.00 |
| Dec 31, 2024 | -90,986.00 |
| Sep 30, 2024 | -908,628.00 |
| Jun 30, 2024 | -453,683.00 |
| Mar 31, 2024 | 842,187.00 |
| Dec 31, 2023 | 604,127.00 |
| Sep 30, 2023 | -180,380.00 |
| Jun 30, 2023 | -505,773.00 |
| Mar 31, 2023 | 112,702.00 |
| Dec 31, 2022 | 630,161.00 |
| Sep 30, 2022 | 349,043.00 |
| Jun 30, 2022 | 146,918.00 |
| Mar 31, 2022 | 82,520.00 |
| Dec 31, 2021 | 90,893.00 |
| Sep 30, 2021 | 126,623.00 |